Tagged With Pharmaceutical Industry

Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods' big burger change, and a look at uBiome's board


Dispensed: Tim Ferriss is backing psychedelic research, how to change your business model as told by pitch decks, and how much money healthcare CEOs make


Healthcare CEOs make as much as $26 million a year. Here's what the industry's top executives earned in 2018.



A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political crosshairs


Colorado became the first state to cap the monthly cost of insulin at $100. Here's why the life-saving drug is so expensive.


Pharma companies want the government to do something about high drug prices, so long as it's not forcing them to lower their drug prices



The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.


Everybody is talking about the high cost of prescription drugs. Here's who's actually responsible for the prices you pay.


Pharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drug


Dispensed: What we saw at JPMorgan's big healthcare investor conference


Bristol-Myers Squibb is buying Celgene in a $74 billion deal


Cigna is closing its $67 billion deal with Express Scripts, creating a new healthcare giant



Botox is made from the deadliest toxin on earth. Then we started injecting it in our faces.


CVS officially completed its $70 billion deal with Aetna almost a year after it was announced, creating a new kind of healthcare company


Amazon is threatening the future of independent pharmacies. Here's how they're fighting back.


Take a look inside Walgreens' futuristic store where it's plotting new ways to take on Amazon and CVS



A pill to treat peanut allergies is getting closer to reality — but a new study shows the drug can have some harsh side effects


Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.


Novartis is going after a $5 billion market with a new treatment for vision loss. That's a big threat to Regeneron


Trump's new plan to drive down drug prices to fight 'global freeloaders' sounds exactly like what those 'freeloaders' are already doing